Investigating Trends in Quality of Life in Patients with Idiopathic Pulmonary Fibrosis (IPF) Under Treatment with Nintedanib (QUALIFY IPF) First published 08/10/2018 Last updated 19/10/2026 EU PAS number:EUPAS25664 Study Finalised